Andy Chevigné and his group, RTI-5152-twelve is postulated to enhance the amounts of opioid peptides that bind to classical opioid receptors while in the brain, leading to heightened painkilling action. The LIH-RTI analysis groups set up a collaboration agreement and submitted a joint patent software in December 2020. Note: https://felixavlcr.imblogs.net/79165263/5-simple-statements-about-what-is-conolidine-explained